Crossmark

Naringenin and its structural analogues inhibit CDK2: a combined MD-MMGBSA and protein–ligand interaction study for colon cancer

Published Online: 2025-09-18

Authors

Dhiya, Francis

Sindhu, K. S.

Kavitha, J.

Jibin, Varughese

Maria, Vincent

Abi, T. G.
License Information

Text and Data Mining valid from 2025-09-18

Version of Record valid from 2025-09-18
More Information

Article History

Received: 23 October 2024

Accepted: 25 August 2025

First Online: 18 September 2025

Declarations

:

: The authors declare no competing interests.

Document is current